Booz Allen Hamilton Holding Corporation (BAH)
BAH Price and Sentiment
BAH Latest news
Booz Allen (BAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Booz Allen Hires Retired Astronaut and Former USGS Director Dr. Jim Reilly to Advise Aerospace Account2021-10-19 08:00
MCLEAN, Va.--(BUSINESS WIRE)--Booz Allen Hamilton (NYSE: BAH) announced that Dr. James F. Reilly II, PhD, a retired NASA astronaut and the former Director of the United States Geological Survey (USGS), has joined the firm as an executive advisor. In this role, he will collaborate with a wide range of partners—the Department of Defense, National Oceanic and Atmospheric Administration, NASA, intelligence community agencies, universities, and the commercial space industry—on innovative solutions f
Booz Allen Hamilton is one of the market leaders for US government technical and engineering services contracting. The company is a Dividend Challenger with nine years of dividend growth at a double-digit rate.
MCLEAN, Va.--(BUSINESS WIRE)--Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of management and technology consulting firm Booz Allen Hamilton, is planning to host its 2021 Investor Day in New York City on Tuesday, October 5th from 9 a.m. – 12 p.m. The event will include presentations by Chief Executive Officer Horacio Rozanski, Chief Financial Officer Lloyd Howell and other executives. Booz Allen leaders will engage in a conversation on the firm's growth strategy and mu
Even though we've all seen this movie before, the suspense is real every time.
Is Booz Allen Hamilton (BAH) a great pick from the value investor's perspective right now? Read on to know more.
In 2019, I wrote two articles detailing the unsustainable, debt-fueled bubble that is Chinese real estate. The probable collapse of Chinese real estate developer Evergrande could be the first of many dominoes to fall for the Chinese economy.
Booz Allen Hamilton Holding Corp (NYSE: BAH) has won a position on the Biomedical Information Technology, Software Development, and Informatics Support (BITSDIS) contract. BITSDIS is a five-year IDIQ contract worth up to $350 million to support the National Institutes of Health (NIH) National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology (CBIIT).
Booz Allen Wins a Position on BITSDIS – a $350M Biomedical Informatics & IT Support Contract for the National Cancer Institute2021-09-21 08:00
MCLEAN, Va.--(BUSINESS WIRE)--Booz Allen Hamilton (NYSE: BAH) announced today it won a position on Biomedical Information Technology, Software Development, and Informatics Support (BITSDIS), a five-year Indefinite-Delivery Indefinite-Quantity (IDIQ) contract worth up to $350 million to support the National Institutes of Health (NIH) National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology (CBIIT). As a part of this IDIQ, Booz Allen was awarded a $29.9 million
Booz Allen Hamilton to Host Conference Call to Discuss Second Quarter Fiscal 2022 Results on Friday, October 29, 20212021-09-17 08:00
MCLEAN, Va.--(BUSINESS WIRE)---- $BAH #earnings--Booz Allen will host a conference call at 8 a.m. EDT on Friday, October 29, 2021, to discuss financial results for the Second Quarter of FY22.